| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Loss before income taxes | -17,454 | -7,420 | -8,194 | -7,526 |
| Benefit (provision) for income taxes | 0 | 0 | - | - |
| Net loss | -17,454 | -7,420 | -8,194 | -7,526 |
| Other comprehensive loss, net of tax | 0 | 0 | - | - |
| Comprehensive loss | -17,454 | -7,420 | -8,194 | -7,526 |
| Basic (in dollars per share) | -0.25 | -0.12 | -0.24 | -0.29 |
| Basic (in shares) | 70,636,887 | 63,376,392 | 33,884,920 | 26,145,080 |
| Diluted (in dollars per share) | -0.25 | -0.12 | -0.24 | -0.29 |
| Diluted (in shares) | 70,636,887 | 63,376,392 | 33,884,920 | 26,145,080 |
Opus Genetics, Inc. (IRD)
Opus Genetics, Inc. (IRD)